All Updates

All Updates

icon
Filter
Funding
Onego Bio raises USD 40 million in Series A funding to boost manufacturing and commercialization
Plant-based Dairy & Egg
Apr 2, 2024
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Plant-based Dairy & Egg

Plant-based Dairy & Egg

Apr 2, 2024

Onego Bio raises USD 40 million in Series A funding to boost manufacturing and commercialization

Funding

  • Onego Bio, a Finnish plant-based egg producer, has raised USD 40 million in Series A funding led by NordicNinja, with participation from Tesi, EIT Food, Agronomics, Maki.vc, and Holdix and Turret, among others. This round also included USD 10 million in non-dilutive funding from Business Finland.

  • The new funding will be used to support its North American commercialization efforts, including scaling production capacity and increasing the headcount of the US commercial team. Further, the company will partner with co-manufacturers to expedite its market entry process.

  • Analyst QuickTake: Onego Bio uses a combination of precision fermentation and cellular agriculture to develop Bioalbumen (animal-free egg protein). The company is on track to commercialize Bioalbumen in the US with self-affirmed GRAS status and a "no objections letter" from the FDA expected soon.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.